Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, SULIMAN SHEHNAAZ, holds the title of Director at 10x Genomics, Inc..
On 2026-09-22, the insider transacted 5,723 shares.The shares were transacted at a weighted average price of $81.19 per share, resulting in a total market-relevant value of $465K.
SULIMAN SHEHNAAZ (Director) sold $465K of $TXG
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.